GMED Globus Medical Inc

Price (delayed)

$53.99

Market cap

$7.31B

P/E Ratio

49.53

Dividend/share

N/A

EPS

$1.09

Enterprise value

$7.36B

Based in Audubon, Pennsylvania, Globus Medical, Inc. was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing ...

Highlights
Globus Medical's revenue has surged by 53% YoY and by 28% QoQ
The gross profit has grown by 34% YoY and by 17% from the previous quarter
GMED's equity has surged by 117% year-on-year but it is down by 4.5% since the previous quarter
GMED's quick ratio is down by 37% year-on-year but it is up by 16% since the previous quarter
The P/E is 44% more than the last 4 quarters average of 34.5 and 21% more than the 5-year quarterly average of 40.8
The EPS has declined by 42% year-on-year and by 31% since the previous quarter

Key stats

What are the main financial stats of GMED
Market
Shares outstanding
135.37M
Market cap
$7.31B
Enterprise value
$7.36B
Valuations
Price to book (P/B)
1.86
Price to sales (P/S)
3.89
EV/EBIT
50.68
EV/EBITDA
25.39
EV/Sales
4.69
Earnings
Revenue
$1.57B
EBIT
$145.26M
EBITDA
$290M
Free cash flow
$165.23M
Per share
EPS
$1.09
Free cash flow per share
$1.46
Book value per share
$29.01
Revenue per share
$13.87
TBVPS
$24.11
Balance sheet
Total assets
$5.09B
Total liabilities
$1.09B
Debt
$520.4M
Equity
$4B
Working capital
$1.52B
Liquidity
Debt to equity
0.13
Current ratio
4.88
Quick ratio
2.6
Net debt/EBITDA
0.18
Margins
EBITDA margin
18.5%
Gross margin
65.1%
Net margin
7.8%
Operating margin
8.5%
Efficiency
Return on assets
3.3%
Return on equity
4.1%
Return on invested capital
7.1%
Return on capital employed
3.1%
Return on sales
9.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GMED stock price

How has the Globus Medical stock price performed over time
Intraday
-0.86%
1 week
-2.3%
1 month
-1.01%
1 year
-7.46%
YTD
1.31%
QTD
1.31%

Financial performance

How have Globus Medical's revenue and profit performed over time
Revenue
$1.57B
Gross profit
$1.02B
Operating income
$133.14M
Net income
$122.87M
Gross margin
65.1%
Net margin
7.8%
The company's operating margin has shrunk by 62% YoY and by 41% QoQ
The net margin has dropped by 58% year-on-year and by 40% since the previous quarter
Globus Medical's revenue has surged by 53% YoY and by 28% QoQ
The operating income has decreased by 42% YoY and by 25% QoQ

Growth

What is Globus Medical's growth rate over time

Valuation

What is Globus Medical stock price valuation
P/E
49.53
P/B
1.86
P/S
3.89
EV/EBIT
50.68
EV/EBITDA
25.39
EV/Sales
4.69
The P/E is 44% more than the last 4 quarters average of 34.5 and 21% more than the 5-year quarterly average of 40.8
The EPS has declined by 42% year-on-year and by 31% since the previous quarter
GMED's equity has surged by 117% year-on-year but it is down by 4.5% since the previous quarter
The stock's P/B is 47% less than its 5-year quarterly average of 3.5 and 19% less than its last 4 quarters average of 2.3
Globus Medical's revenue has surged by 53% YoY and by 28% QoQ
GMED's P/S is 40% lower than its 5-year quarterly average of 6.5 and 19% lower than its last 4 quarters average of 4.8

Efficiency

How efficient is Globus Medical business performance
The ROA has dropped by 65% year-on-year and by 39% since the previous quarter
Globus Medical's return on equity has shrunk by 62% YoY and by 36% QoQ
The return on sales has dropped by 58% year-on-year and by 35% since the previous quarter
GMED's ROIC has dropped by 56% year-on-year and by 26% since the previous quarter

Dividends

What is GMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GMED.

Financial health

How did Globus Medical financials performed over time
GMED's total assets has surged by 145% year-on-year but it is down by 5% since the previous quarter
GMED's quick ratio is down by 37% year-on-year but it is up by 16% since the previous quarter
The debt is 87% smaller than the equity
GMED's equity has surged by 117% year-on-year but it is down by 4.5% since the previous quarter
The company's debt to equity rose by 8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.